TY  - GEN

T1  - 34655 Integrated analysis of abrocitinib for the treatment of adolescents with moderate-to-severe atopic dermatitis from the phase 3 clinical trial program

PY  - 2022/09/01

AU  - Paller A

AU  - Eichenfield LF

AU  - Cork MJ

ED  - 

Y2  - 2024/12/22

ER  -